CLINICAL USE OF CEFMENOXIME (SCE-1365) FOR THE PATIENTS WITH ACUTE PERITONITIS

We used cefmenoxime (CMX, SCE-1365) for the patients with acute peritonitis to examine its clinical efficacy. Acute peritonitis of 10 cases were caused by ruptured appendix or by perforation of a viscus from duodenal ulcer or by leakage from suture of a viscus. Clinical efficacy of cefmenoxime was e...

Full description

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 29; no. Supplement1; pp. 680 - 686
Main Authors HIRABAYASHI, MASAHIKO, SASAKI, OSAMU, KANEMATSU, TAKASHI, YOSHIDA, TAKERO, INOKUCHI, KIYOSHI, FURUSAWA, MOTONOSUKE, HARAGUCHI, YUKIAKI, SANNOHE, YASUO, SAKU, MOTONORI
Format Journal Article
LanguageJapanese
Published Japanese Society of Chemotherapy 25.06.1981
Online AccessGet full text

Cover

More Information
Summary:We used cefmenoxime (CMX, SCE-1365) for the patients with acute peritonitis to examine its clinical efficacy. Acute peritonitis of 10 cases were caused by ruptured appendix or by perforation of a viscus from duodenal ulcer or by leakage from suture of a viscus. Clinical efficacy of cefmenoxime was evaluated with decrease in purulent discharge, falls of temperature and/or normalization of leucocytosis. It was excellent in 3 cases, good in 6 and fair in 1. Clinical improvement was corre lated well with disappearence of causative bacilli in the discharge. Good transfer of cefmenoxime into ascites from i.v. infusion was ascertained. No side effect was noticed.
ISSN:0009-3165
1884-5894
DOI:10.11250/chemotherapy1953.29.Supplement1_680